-
Je něco špatně v tomto záznamu ?
Docking studies and effects of syn-anti isomery of oximes derived from pyridine imidazol bicycled systems as potential human acetylcholinesterase reactivators
Ana Paula Guimaraes, Tanos Celmar Costa Franca, Teodorico Castro Ramalho, Magdalena Nascimento Renno, Elaine Fontes Ferreira da Cunha, Karina Silvia Matos, Daiana Teixeira Mancini, Kamil Kuca
Jazyk angličtina Země Česko
NLK
Free Medical Journals
od 2003 do 2013
Freely Accessible Science Journals
od 2003 do 2013
ROAD: Directory of Open Access Scholarly Resources
od 2002
- MeSH
- acetylcholinesterasa chemie MeSH
- chemické bojové látky MeSH
- financování organizované MeSH
- molekulární modely MeSH
- neurotoxiny MeSH
- obidoxim chlorid chemická syntéza MeSH
- organofosforové sloučeniny chemie MeSH
- oximy chemie MeSH
- počítačová simulace MeSH
- pralidoximové sloučeniny chemická syntéza MeSH
- racionální návrh léčiv MeSH
- reaktivátory cholinesterázy chemická syntéza MeSH
- trimedoxim chemická syntéza MeSH
- vazebná místa MeSH
In order to contribute to a better understanding of the mechanism of action of oximes, we evaluated the affinities of 10 new oximes, derived from pyridine-imidazol bicycled systems, for human acetylcholinesterase (HssAChE) complexed with tabun, by estimating their docking energy values and comparing of the values obtained to known oximes using the software Molegro Virtual Docker (MVD)®. We evaluated the influence of the position of the oxime group as substituent in the structures and, also, the influence of the oxime group syn-anti isomery on the docking score values for all the molecules studied. Results suggest that: the affinities of the 10 new oximes for the tabun inhibited HssAChE active site are better than pralidoxime’s and similar to trimedoxime’s; the meta-pralidoxime could have more affinity for the HssAChE active site and the oximes’ anti isomers could present slightly better affinities for the HssAChE active site than the syn isomers.
Citace poskytuje Crossref.org
Lit.: 19
- 000
- 00000naa 2200000 a 4500
- 001
- bmc11037489
- 003
- CZ-PrNML
- 005
- 20111210222717.0
- 008
- 111017s2011 xr e eng||
- 009
- AR
- 024 7_
- $a 10.2478/v10136-009-0037-1 $2 doi
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Guimaraes, Ana Paula
- 245 10
- $a Docking studies and effects of syn-anti isomery of oximes derived from pyridine imidazol bicycled systems as potential human acetylcholinesterase reactivators / $c Ana Paula Guimaraes, Tanos Celmar Costa Franca, Teodorico Castro Ramalho, Magdalena Nascimento Renno, Elaine Fontes Ferreira da Cunha, Karina Silvia Matos, Daiana Teixeira Mancini, Kamil Kuca
- 314 __
- $a Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense, Military Institute of Engineering, Rio de Janeiro, Brazil, Chemistry Department, Federal University of Lavras, Lavras, Brazil
- 504 __
- $a Lit.: 19
- 520 9_
- $a In order to contribute to a better understanding of the mechanism of action of oximes, we evaluated the affinities of 10 new oximes, derived from pyridine-imidazol bicycled systems, for human acetylcholinesterase (HssAChE) complexed with tabun, by estimating their docking energy values and comparing of the values obtained to known oximes using the software Molegro Virtual Docker (MVD)®. We evaluated the influence of the position of the oxime group as substituent in the structures and, also, the influence of the oxime group syn-anti isomery on the docking score values for all the molecules studied. Results suggest that: the affinities of the 10 new oximes for the tabun inhibited HssAChE active site are better than pralidoxime’s and similar to trimedoxime’s; the meta-pralidoxime could have more affinity for the HssAChE active site and the oximes’ anti isomers could present slightly better affinities for the HssAChE active site than the syn isomers.
- 650 _2
- $a financování organizované $7 D005381
- 650 _2
- $a acetylcholinesterasa $x chemie $7 D000110
- 650 _2
- $a reaktivátory cholinesterázy $x chemická syntéza $7 D002801
- 650 _2
- $a chemické bojové látky $7 D002619
- 650 _2
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a oximy $x chemie $7 D010091
- 650 _2
- $a neurotoxiny $7 D009498
- 650 _2
- $a počítačová simulace $7 D003198
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a organofosforové sloučeniny $x chemie $7 D009943
- 650 _2
- $a pralidoximové sloučeniny $x chemická syntéza $7 D011220
- 650 _2
- $a obidoxim chlorid $x chemická syntéza $7 D009768
- 650 _2
- $a trimedoxim $x chemická syntéza $7 D014289
- 650 _2
- $a vazebná místa $7 D001665
- 700 1_
- $a França, Tanos Celmar Costa
- 700 1_
- $a Ramalho, Teodorico Castro
- 700 1_
- $a Rennó, Magdalena Nascimento
- 700 1_
- $a Cunha, Elaine Fontes Ferreira da
- 700 1_
- $a Matos, Karina Silvia
- 700 1_
- $a Mancini, Daiana Teixeira
- 700 1_
- $a Kuča, Kamil, $d 1978- $7 xx0041831
- 773 0_
- $w MED00012667 $t Journal of applied biomedicine $g Roč. 9, č. 3 (2011), s. 163-171 $x 1214-021X
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2011/03/06.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 2
- 990 __
- $a 20111016074143 $b ABA008
- 991 __
- $a 20111129132948 $b ABA008
- 999 __
- $a ok $b bmc $g 883507 $s 747671
- BAS __
- $a 3
- BMC __
- $a 2011 $b 9 $c 3 $d 163-171 $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $a 2011-53/vthv